HighTower Advisors’s 1Life Healthcare ONEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-13,606
| Closed | -$227K | – | 3750 |
|
|
2022
Q4 | $227K | Sell |
13,606
-4,507
| -25% | -$76.1K | ﹤0.01% | 2671 |
|
|
2022
Q3 | $311K | Buy |
18,113
+2,633
| +17% | +$41.3K | ﹤0.01% | 2319 |
|
|
2022
Q2 | $121K | Buy |
15,480
+101
| +0.7% | +$868 | ﹤0.01% | 2754 |
|
|
2022
Q1 | $170K | Sell |
15,379
-2,665
| -15% | -$29.9K | ﹤0.01% | 2885 |
|
|
2021
Q4 | $317K | Buy |
18,044
+1,025
| +6% | +$19.9K | ﹤0.01% | 2452 |
|
|
2021
Q3 | $342K | Sell |
17,019
-30,332
| -64% | -$780K | ﹤0.01% | 2327 |
|
|
2021
Q2 | $1.57M | Sell |
47,351
-10,108
| -18% | -$382K | ﹤0.01% | 1376 |
|
|
2021
Q1 | $2.25M | Buy |
57,459
+164
| +0.3% | +$7.7K | 0.01% | 1073 |
|
|
2020
Q4 | $2.5M | Buy |
+57,295
| New | +$1.96M | 0.01% | 814 |
|
|
2020
Q3 | – | Sell |
-923
| Closed | -$32K | – | 2738 |
|
|
2020
Q2 | $32K | Buy |
+923
| New | +$26K | ﹤0.01% | 2219 |
|
HighTower Advisors's ONEM Position: Q1 2023 in Review
HighTower Advisors sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 13,606 shares — an estimated $227K sold.
HighTower Advisors first reported a position in ONEM in Q2 2020 and held it in 10 quarters. The position peaked at $2.5M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.
- HighTower Advisors reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
- HighTower Advisors sold 13,606 1Life Healthcare shares in Q1 2023, an estimated $227K.
- HighTower Advisors first reported a position in 1Life Healthcare in Q2 2020 and held it in 10 quarters.
- HighTower Advisors's 1Life Healthcare position peaked at $2.5M in Q4 2020.
- 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.
Based on HighTower Advisors's 13F filing for Q1 2023, filed 12 May 2023.